These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34589144)
1. LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion. Yin Y; Fan Y; Yu G; Du Y Oncol Lett; 2021 Nov; 22(5):765. PubMed ID: 34589144 [TBL] [Abstract][Full Text] [Related]
2. Tao D; Liang J; Pan Y; Zhou Y; Feng Y; Zhang L; Xu J; Wang H; He P; Yao J; Zhao Y; Ning Q; Wang W; Jiang W; Zheng J; Wu X J Breast Cancer; 2019 Sep; 22(3):375-386. PubMed ID: 31598338 [TBL] [Abstract][Full Text] [Related]
3. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment. Wang ZX; Guo MY; Ren J; Li GS; Sun XG Orthop Surg; 2020 Aug; 12(4):1253-1260. PubMed ID: 32558212 [TBL] [Abstract][Full Text] [Related]
4. [Impact of lysosome-associated protein transmembrane-4 beta on proliferation and invasion of colorectal cancer]. Luo Y; Bian Z; Ye G; Yu M; Wang Z; Qin S; Mu Y; Zhong M Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):606-10. PubMed ID: 26108779 [TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro. Meng F; Chen X; Song H; Lou G; Fu S Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403 [TBL] [Abstract][Full Text] [Related]
6. Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion. Xin F; Yao DW; Fan L; Liu JH; Liu XD Clin Exp Med; 2019 Nov; 19(4):525-534. PubMed ID: 31463832 [TBL] [Abstract][Full Text] [Related]
7. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro. Meng F; Chen X; Song H; Lou G Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850 [TBL] [Abstract][Full Text] [Related]
8. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
9. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro. Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476 [TBL] [Abstract][Full Text] [Related]
10. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells. Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157 [TBL] [Abstract][Full Text] [Related]
11. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR. Wang L; Meng Y; Zhang QY BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109 [TBL] [Abstract][Full Text] [Related]
12. ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis. Xu N; Qu GY; Wu YP; Lin YZ; Chen DN; Li XD; Chen SH; Huang JB; Zheng QS; Xue XY; Wei Y J Cell Biochem; 2020 Jan; 121(1):231-243. PubMed ID: 31190401 [TBL] [Abstract][Full Text] [Related]
13. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Li S; Xu JJ; Zhang QY Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121 [TBL] [Abstract][Full Text] [Related]
15. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma. Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920 [TBL] [Abstract][Full Text] [Related]
16. LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy. Chu C; Niu X; Ou X; Hu C Onco Targets Ther; 2019; 12():5661-5677. PubMed ID: 31410015 [TBL] [Abstract][Full Text] [Related]
17. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells. Pang K; Zhang Z; Hao L; Shi Z; Chen B; Zang G; Dong Y; Li R; Liu Y; Wang J; Zhang J; Cai L; Han X; Han C BMC Cancer; 2019 Mar; 19(1):225. PubMed ID: 30866868 [TBL] [Abstract][Full Text] [Related]
18. Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B. Yang Y; Xu J; Zhang Q Oncol Lett; 2018 May; 15(5):7923-7933. PubMed ID: 29725479 [TBL] [Abstract][Full Text] [Related]
19. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells. Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells. Gao X; Wen X; He H; Zheng L; Yang Y; Yang J; Liu H; Zhou X; Yang C; Chen Y; Chen M; Zhang S PeerJ; 2020; 8():e9078. PubMed ID: 32377458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]